BioLASCO Taiwan Market Cap

BioLASCO Taiwan has a market cap or net worth of 868.25 million as of June 5, 2025. Its market cap has decreased by -8.01% in one year.

Market Cap

868.25M

Enterprise Value

824.07M

Revenue

304.65M

Ranking

n/a

PE Ratio

19.37

Stock Price

33.90

Market Cap Chart

Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 868.25M, a decrease of -45.08%. That is a compound annual growth rate of -7.76%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2025	868.25M	2.42%
Dec 31, 2024	847.76M	-0.30%
Dec 29, 2023	850.32M	11.22%
Dec 30, 2022	764.52M	-1.97%
Dec 30, 2021	779.89M	-13.74%
Dec 31, 2020	904.10M	-7.47%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	173.35B
Caliway Biopharmaceuticals	141.78B
Bora Pharmaceuticals Co., LTD.	84.74B
Lotus Pharmaceutical	61.87B
Polaris Group	31.40B
Lumosa Therapeutics	29.88B
Center Laboratories	28.89B
Oneness Biotech	27.74B

Market Cap Rankings